121 related articles for article (PubMed ID: 36208256)
1. [Expression of Wilms' Tumor 1 Gene in Bone Marrow of Patients with Myelodysplastic Syndrome and Its Clinical Significance].
Pan DQ; Zhao WS; Yin CX; He H; Lin R; Zhao K; Ye JY; Liu QF; Dai M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1501-1507. PubMed ID: 36208256
[TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor 1 expression combined with genetic mutations for prognostic assessment in MDS.
Pan D; Zhao W; Jiang Q; Yin C; He H; Liao L; Ye J; Dai M
Leuk Lymphoma; 2023 Apr; 64(4):856-864. PubMed ID: 36905177
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of the Wilms' tumor 1 mRNA expression in childhood myelodysplastic syndrome].
Cheng YF; Zhang LP; Liu YR; Qin YZ; Wu J; Liu GL
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):536-40. PubMed ID: 22967413
[TBL] [Abstract][Full Text] [Related]
4. [Changes of WT1 mRNA expression level in patients with myelodysplastic syndromes after hypomethylating agents and its prognostic significance].
Zhang HY; Geng SX; Li MM; Lai PL; Deng CX; Lu ZS; Huang X; Wang YL; Weng JY; Du X
Zhonghua Xue Ye Xue Za Zhi; 2019 May; 40(5):417-421. PubMed ID: 31207708
[No Abstract] [Full Text] [Related]
5. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
Cilloni D; Gottardi E; Messa F; Fava M; Scaravaglio P; Bertini M; Girotto M; Marinone C; Ferrero D; Gallamini A; Levis A; Saglio G;
J Clin Oncol; 2003 May; 21(10):1988-95. PubMed ID: 12743153
[TBL] [Abstract][Full Text] [Related]
6. [Expression of WT1 and PRAME gene in bone marrow and peripheral blood samples of patients with myelodysplastic syndrome].
Lu D; Qin YZ; Li LD; Shi HX; Lai YY; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):370-6. PubMed ID: 24763007
[TBL] [Abstract][Full Text] [Related]
7. The level of bone marrow WT1 message is a useful marker to differentiate myelodysplastic syndromes with low blast percentage from cytopenia due to other reasons.
Baba M; Hata T; Tsushima H; Mori S; Sasaki D; Turuta K; Hasegawa H; Ando K; Sawayama Y; Imanishi D; Taguchi J; Yanagihara K; Tomonaga M; Kamihira S; Miyazaki Y
Intern Med; 2015; 54(5):445-51. PubMed ID: 25758068
[TBL] [Abstract][Full Text] [Related]
8. Wilms Tumor 1 (WT1) mRNA Expression Level at Diagnosis Is a Significant Prognostic Marker in Elderly Patients with Myelodysplastic Syndrome.
Nagasaki J; Aoyama Y; Hino M; Ido K; Ichihara H; Manabe M; Ohta T; Mugitani A
Acta Haematol; 2017; 137(1):32-39. PubMed ID: 27866185
[TBL] [Abstract][Full Text] [Related]
9. [Wilms' tumor-1 gene expression in myelodysplastic syndrome and its changes in the process of myelodysplastic syndrome transforming into acute leukemia].
Yang JK; Li JL; Li ZG; Li ZG; Liu PJ; Li JY; Lü HR; Deng Q; Lin XM; Cao JN
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):557-9. PubMed ID: 12971856
[TBL] [Abstract][Full Text] [Related]
10. Associations between the peripheral blood Wilms tumor gene 1 level and both bone marrow blast cells and the prognosis in patients with myelodysplastic syndrome.
Mashima K; Ikeda T; Toda Y; Ito S; Umino K; Minakata D; Nakano H; Morita K; Yamasaki R; Kawasaki Y; Sugimoto M; Ashizawa M; Yamamoto C; Fujiwara S; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
Leuk Lymphoma; 2019 Mar; 60(3):703-710. PubMed ID: 30188227
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of WT1 and PRAME predicts poor outcomes of patients with myelodysplastic syndromes with thrombocytopenia.
Huang QS; Wang JZ; Qin YZ; Zeng QZ; Jiang Q; Jiang H; Lu J; Liu HX; Liu Y; Wang JB; Su L; Zhang HY; Li ZL; Gao SJ; Huang B; Liu YY; Liu YR; Xu LP; Huang XJ; Zhang XH
Blood Adv; 2019 Nov; 3(21):3406-3418. PubMed ID: 31714962
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.
Kobayashi S; Ueda Y; Nannya Y; Shibayama H; Tamura H; Ogata K; Akatsuka Y; Usuki K; Ito Y; Okada M; Suzuki T; Hata T; Matsuda A; Tohyama K; Kakumoto K; Koga D; Mitani K; Naoe T; Sugiyama H; Takaku F
Cancer Biomark; 2016 Mar; 17(1):21-32. PubMed ID: 27062571
[TBL] [Abstract][Full Text] [Related]
13. [Expression of WT1 Gene in Bone Marrow of Patients with Acute Myeloid Leukemia and Its Influence on Prognosis].
Zheng YT; Li BX; Sun YJ; Yu CL; Sun QY; Qiao JH; Hu KX; Zuo HL; Dong Z; Ai HS; Guo M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):649-54. PubMed ID: 27342485
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival.
Santamaría C; Ramos F; Puig N; Barragán E; de Paz R; Pedro C; Insunza A; Tormo M; Del Cañizo C; Diez-Campelo M; Xicoy B; Salido E; Sánchez del Real J; Hernández M; Chillón C; Sanz GF; García-Sanz R; San Miguel JF; González M
Ann Hematol; 2012 Dec; 91(12):1887-95. PubMed ID: 22875062
[TBL] [Abstract][Full Text] [Related]
15. The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes.
Tamaki H; Ogawa H; Ohyashiki K; Ohyashiki JH; Iwama H; Inoue K; Soma T; Oka Y; Tatekawa T; Oji Y; Tsuboi A; Kim EH; Kawakami M; Fuchigami K; Tomonaga M; Toyama K; Aozasa K; Kishimoto T; Sugiyama H
Leukemia; 1999 Mar; 13(3):393-9. PubMed ID: 10086730
[TBL] [Abstract][Full Text] [Related]
16. [The Distribution and Significance of Activated T Cells and Lymphocyte Subsets in Myelodysplastic Syndrome].
Hu ZL; Yang YL; Zhang PP; Pan SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):469-475. PubMed ID: 37096521
[TBL] [Abstract][Full Text] [Related]
17. Wilms' tumor-1 transcript in peripheral blood helps diagnose acute myeloid leukemia and myelodysplastic syndrome in patients with pancytopenia.
Yamauchi T; Matsuda Y; Takai M; Tasaki T; Hosono N; Negoro E; Ikegaya S; Takagi K; Kishi S; Yoshida A; Urasaki Y; Ueda T
Anticancer Res; 2012 Oct; 32(10):4479-83. PubMed ID: 23060576
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5-azacytidine: Identification of responding patients.
Santaliestra M; Garrido A; Carricondo M; Bussaglia E; Pratcorona M; Blanco ML; Gich I; Hoyos M; Esquirol A; García-Cadenas I; Brunet S; Martino R; Sierra J; Nomdedéu JF
Eur J Haematol; 2019 Sep; 103(3):208-214. PubMed ID: 31211880
[TBL] [Abstract][Full Text] [Related]
19. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome.
Bergmann L; Miething C; Maurer U; Brieger J; Karakas T; Weidmann E; Hoelzer D
Blood; 1997 Aug; 90(3):1217-25. PubMed ID: 9242555
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.
Ueda Y; Mizutani C; Nannya Y; Kurokawa M; Kobayashi S; Takeuchi J; Tamura H; Ogata K; Dan K; Shibayama H; Kanakura Y; Niimi K; Sasaki K; Watanabe M; Emi N; Teramura M; Motoji T; Kida M; Usuki K; Takada S; Sakura T; Ito Y; Ohyashiki K; Ogawa H; Suzuki T; Ozawa K; Imai K; Kasai M; Hata T; Miyazaki Y; Morita Y; Kanamaru A; Matsuda A; Tohyama K; Koga D; Tamaki H; Mitani K; Naoe T; Sugiyama H; Takaku F
Leuk Lymphoma; 2013 Jul; 54(7):1450-8. PubMed ID: 23110324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
